Results 271 to 280 of about 6,997,331 (310)
Some of the next articles are maybe not open access.
Pharmacoepidemiology and Drug Safety, 2019
Although a series of serious adverse events have continually raised concerns about the potential toxicity of traditional Chinese medicine injections (TCM injections), studies on this subject are still sparse.
Haona Li +4 more
semanticscholar +1 more source
Although a series of serious adverse events have continually raised concerns about the potential toxicity of traditional Chinese medicine injections (TCM injections), studies on this subject are still sparse.
Haona Li +4 more
semanticscholar +1 more source
Preclinical Safety Profile of Brimonidine
European Journal of Ophthalmology, 1996Brimonidine is a selective α2-adrenergic agonist developed for lowering intraocular pressure in glaucoma patients. Since brimonidine will be used in long-term theraphy, the safety of this drug is an important feature for its clinical success. Brimonidine has been evaluated in a number of safety studies using doses much greater than
O V, Angelov +5 more
openaire +2 more sources
Propranolol Safety Profile in Children
Current Drug Safety, 2011Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the management of hemangiomas in addition to other indications.
Mortada, El-Shabrawi, Fetouh, Hassanin
openaire +2 more sources
A review of the safety profile of teicoplanin
Journal of Antimicrobial Chemotherapy, 1991Safety of teicoplanin has been assessed in 3377 patients treated in Europe up to the end of June 1990. One or more adverse events were experienced by 10% of patients. Age and teicoplanin dose had no significant effect on the incidence or type of adverse event.
P G, Davey, A H, Williams
openaire +2 more sources
Safety Profile of the Fluoroquinolones
Drug Safety, 2010The fluoroquinolone class of antibacterial agents are among the most frequently prescribed drugs, with utility in a broad range of bacterial infections. Although very useful agents, the fluoroquinolones as a class are associated with a number of adverse events, some with considerable clinical significance. In the past 15-20 years, tolerability concerns
openaire +2 more sources
Methotrexate: Improving safety profile
Australasian Journal of Dermatology, 2006SUMMARYOver the past 10 years, there have been 137 patient safety incidents in England associated with methotrexate prescribing. Recent reports show that Australia has similar concerns. Using the valuable tool of an audit, we reviewed our departmental prescribing practices for 49 patients with psoriasis on methotrexate.
Claire, Grills, Susan, Burge
openaire +2 more sources
Mesotherapy: Safety profile and management of complications
Journal of Cosmetic Dermatology, 2019Mesotherapy is a procedure that involves the injection of active substances into the dermis and subcutaneous tissue in order to treat several local medical and cosmetic conditions. Despite being considered as a relatively safe method, a series of adverse
K. Plachouri, S. Georgiou
semanticscholar +1 more source
Clinical safety profile of cefodizime
Journal of Antimicrobial Chemotherapy, 1990Data from ten clinical trials involving 1189 patients treated with 1 g bd of cefodizime iv or im were analysed for adverse effects and abnormal laboratory test results. In total, side-effects possibly or probably related to cefodizime occurred in only 1.34% of patients.
openaire +2 more sources
A Profile for Safety Critical Java
10th IEEE International Symposium on Object and Component-Oriented Real-Time Distributed Computing (ISORC'07), 2007We propose a new, minimal specification for real-time Java for safety critical applications. The intention is to provide a profile that supports programming of applications that can be validated against safety critical standards such as DO-178B [15].
Martin Schoeberl +3 more
openaire +2 more sources
Oxaliplatin-safety profile: neurotoxicity
Seminars in Oncology, 2003Oxaliplatin has become an integral part of various chemotherapy protocols, and in advanced colorectal cancer in particular. While oxaliplatin has only mild hematologic and gastrointestinal side effects, its dose-limiting toxicity is a cumulative sensory neurotoxicity that resembles that of cisplatin with the important difference of a more rapid and ...
openaire +2 more sources